Overview

Launching Galderma Online — Smart, Simple Sites for Doctors and Patients.

I created four impactful websites for Galderma’s global launch of Nemolizumab—two sites for both patients and healthcare professionals (HCPs) for Prurigo Nodularis (PN) and two for Atopic Dermatitis (AD). The goal? Boost digital engagement for HCPs and patients by delivering clear, helpful information while adhering to strict regulatory guidelines.

Key Results

• 70% increase in resource downloads on the HCP site.

• 50% increase in form submissions on the patient site.

• Successful global launch of all four HCP and patient websites.

Final designs, click or tap on images to expand. Live sites can be seen here:

https://www.nemluviohcp.com/ | https://www.nemluvio.com/

Mapping Real Journeys to Solve Real Problems.

Insights from the interviews were transformed into detailed user journey maps, capturing the unique experiences and challenges faced by both HCPs and patients. These maps provided a clear visual narrative, highlighting pain points, goals, and opportunities to improve their experiences—ensuring our designs addressed the real needs of each audience.

Key Findings:

• AD Patients: Often face stigma, delayed diagnosis, and limited tailored care.

• PN Patients: Struggle with low disease awareness and misdiagnosis, especially when it comes to chronic itch management.

Solution

Two Audiences, Four Sites—One Seamless Experience.

I designed intuitive wireframes and prototypes tailored to each audience:

• For HCPs: Fast, intuitive navigation for clinical information.

• For Patients: Simple, supportive layouts to make medical information easy to understand.

I iterated designs based on stakeholder feedback to ensure usability and compliance.

Click or tap image to expand

Impact

What We Achieved - Big Wins for HCPs and Patients.

After the launch, the results spoke for themselves:

• Doctors now get resources 70% faster.

• Patients feel more supported, with 50% more signing up for help.

These numbers prove we delivered engaging, effective solutions that met the needs of both groups.

Collaboration Across Departments

Tight Deadlines and Strict Rules? We Made It Work.

Collaboration was key. I partnered with:

• Copywriters, developers, and regulatory teams to keep content compliant.

• Project managers and designers to meet tight timelines.

The result? Seamless communication and rapid iteration to ship high-quality, compliant websites on schedule.

Refining the Experience through Accessibility Testing

Making Sites Inclusive and Compliant.

I conducted WCAG accessibility testing, including:

• Manual VPAT audits for compliance.

• Contrast checks and semantic code reviews for usability.

This ensured our sites were not only compliant but also accessible to all users.

Learnings

Balancing Compliance and Usability Is Tough—But Possible.

One of the biggest challenges in this project was balancing strict regulatory compliance with the need for a user-friendly experience. Every decision required careful consideration—whether simplifying medical jargon or designing intuitive navigation—while ensuring we stayed within legal and regulatory boundaries.

This process reinforced the importance of agility and iteration. I learned how to adapt quickly, gather stakeholder feedback, address concerns, and refine designs without sacrificing usability. It also emphasized how critical it is to collaborate early and often across teams, especially when working in industries with tight compliance standards.

Next Steps

Continuous Improvement and Expanding Support for Future Launches.

Looking ahead, the focus is on iterating based on user feedback and enhancing support tools for both HCPs and patients. With the recent Atopic Dermatitis (AD) launch, updates will emphasize improved navigation, expanded patient resources, and further optimization for accessibility.

Beyond these U.S. sites, I also contributed to the global strategy for Galderma’s online presence—helping design their global platform and a dashboard for HCP training. These enhancements will create a consistent, seamless experience for users across regions and ensure Galderma’s digital ecosystem continues to grow and adapt to meet evolving needs.